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Elisabetta Lambertini1, Andrea Lolli1, Federica Vezzali1, Letizia Penolazzi1, Roberto Gambari2 and Roberta Piva1*Abstract
Background: Breast cancer and its metastatic progression is mainly directed by epithelial to mesenchymal
transition (EMT), a phenomenon supported by specific transcription factors and miRNAs.
Methods: In order to investigate a possible correlation between Slug transcription factor and miR-221, we
performed Slug gene silencing in MDA-MB-231 breast cancer cells and evaluated the expression of genes involved
in supporting the breast cancer phenotype, using qRT-PCR and Western blot analysis. Chromatin
immunoprecipitation and wound healing assays were employed to determine a functional link between these
two molecules.
Results: We showed that Slug silencing significantly decreased the level of miR-221 and vimentin, reactivated
Estrogen Receptor α and increased E-cadherin and TRPS1 expression. We demonstrated that miR-221 is a Slug
target gene, and identified a specific region of miR-221 promoter that is transcriptionally active and binds the
transcription factor Slug “in vivo”. In addition, we showed that in Slug-silenced cells, wich retained residual miR-221
(about 38%), cell migration was strongly inhibited. Cell migration was inhibited, but to a less degree, following
complete knockdown of miR-221 expression by transfection with antagomiR-221.
Conclusions: We report for the first time evidence of a correlation between Slug transcription factor and miR-221
in breast cancer cells. These studies suggest that miR-221 expression is, in part, dependent on Slug in breast cancer
cells, and that Slug plays a more important role than miR-221 in cell migration and invasion.
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Epithelial cancers such as breast carcinomas and their
metastatic progression are mainly directed by a phenomenon
referred to as epithelial to mesenchymal transition (EMT)
[1,2]. As well described in several reviews, EMT is supported
by the same transcription factors (TFs) including ZEB factors
and the Snail family of zinc finger proteins both during
embryonic development and the metastatic cascade
[1,3-5]. In addition, specific microRNAs (miRNAs) including
miR-206, miR-221/222, miR-200, miR-141, miR-203,
miR-130a, have been shown to regulate EMT [6-11].
Mounting evidence indicates that the acquisition of an
aggressive cancer phenotype through EMT, as well as
other cellular events, may be understood by evaluating the
regulatory interplay between TFs and miRNAs [12,13].* Correspondence: piv@unife.it
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distribution, and reproduction in any mediumTherefore, recent studies have investigated the interac-
tions among specific miRNAs, TFs and target genes asso-
ciated with this phenomenon. Direct evidence of these
circuits in EMT is still little. Some specific networks have
been described including miR-203 – Snai1 [14], a self-
reinforcing loop miR-1/miR-200 via Slug [15], miR-200/
miR-192 – p53 [16], miR-221/222 – TRPS1 [17], p53/
miR-34 axis [18], and ZEB/miR-200 [19].
To investigate the key regulatory networks underlying
EMT in breast cancer, we evaluated a potential correl-
ation between Slug (SNAI2) transcription factor and
miR-221. The ability of miR-221 and Slug to promote
EMT and induce invasiveness in breast cancer cell lines
has been documented, but crosstalk between these mole-
cules has not been characterized [3,17,20].
Slug is a member of the Snail family of zinc-finger
transcription factors, and, together with Snail (SNAI1),
acts as a master regulator of EMT. Various studies overtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of Slug in human cancers including leukemias [21],
osteosarcoma [22], esophageal carcinomas [23], and
breast cancers [3,24], where Slug expression is strongly
correlated with the loss of E-cadherin. Multiple lines of
evidence suggest that Slug can be considered a marker
of malignancy as well as an attractive target for thera-
peutic modulation of invasiveness in the treatment of
specific cancers [25-28].
miR-221 is often overexpressed in aggressive cancers,
increases cell proliferation and protects cancer cells
against different apoptotic stimuli [29-31]. Recently, the
expression level of miR-221 has been significantly asso-
ciated with Estrogen Receptor alpha (ERα) status in
breast cancer, and several studies have demonstrated
that miR-221 directly targets ERα [9,32,33]. Breast
tumors from patients with high miR-221 plasma levels
tend to be ERα-negative, more aggressive and show
poorer clinical outcomes than ERα positive cancers [34].
In addition, ERα signaling has been correlated with Slug,
and at least two different mechanisms showed that ERα
decreases Slug expression [35-37].
In this study, we knocked down Slug and miR-221 in
ERα-negative breast cancer cells, MDA-MB-231. We
determined a functional correlation between these two
molecules demonstrating “in vivo” interaction between
Slug and miR-221. Rescue experiments with ectopic expres-
sion of miR-221, analysis of the expression of genes involved
in breast cancer phenotype, and wound healing assay, sug-
gested that the largest contribution to the invasion ability of
the cells and their aggressive phenotype comes from
Slug rather than miR-221.
Methods
Cell culture
Human breast cancer cell lines MDA-MB-231 and MDA-
MB-436 were cultured in Dulbecco’s modified Eagle
medium-High Glucose (DMEM-HG) (Euroclone S.p.a.,
Milan, Italy), supplemented with 10% Fetal Calf Serum
(FCS) (Euroclone), 2 mM L-glutamine and 100 U/ml
penicillin-streptomycin.
Transfections
Breast cancer cells were transfected with 30 nM siRNA
against Slug (Invitrogen, Carlsbad, CA) [38], 30 nM
antagomiR-221, 50 nM pre-miR-221 precursor (named
miR-221 mimic) (Ambion Life Technologies, Grand
Island, NY), a non-relevant siRNA (si-Scr) (Medium GC
Stealth RNAi Negative Control Duplex, Invitrogen), a
non-relevant (miR-Scr) mimic and a non-relevant antago-
miR (antagomiR-Scr) (Ambion Life Technologies,
Grand Island, NY). For all transfections Lipofectamine
RNAiMAX (Invitrogen) was used, following the manu-
facturer’s instructions. In brief, cells were plated theday before transfections in 12-well plates. Transfected
cells were grown up to 6 days in a 37°C incubator with
5% CO2. Total RNA and proteins were extracted, and
stored at −80°C for subsequent quantitative RT-PCR or
Western Blot measurements. Each treatment used at
least triplicate samples.
RNA extraction
Total RNA including miRs was extracted from breast
cancer cell lines using an RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s in-
struction and as previously described [39]. Total RNA
was used for reverse-transcription and stored at −80°C.
Briefly, cDNA was synthesized from total RNA (500 ng) in
a 10 μl reaction volume using the TaqMan MicroRNA
Reverse Transcription Kit (Applied Biosystems). The
reactions were incubated first at 16°C for 30 min and
then at 42°C for 30 min followed by inactivation at 85°C
for 5 min.
Quantitative real-time PCR for miRNA and mRNA
quantification
Quantification of miR-221 and miR-222 was performed
using TaqMan MicroRNA Assays (Applied Biosystems),
followed by detection with the CFX96TM PCR detection
system (Bio-Rad, Hercules, CA). The TaqMan Micro-
RNA Assay for U6 snRNA (assay ID: 001973; Applied
Biosystems) was used to normalize the relative abun-
dance of miR-221 and miR-222. For quantification of
Slug, E-cadherin, ERα and TRPS1 mRNAs and pri-
miR-221 the appropriate TaqMan probes were pur-
chased from Applied Biosystems using GAPDH refer-
ence gene for normalization. Relative expression was
calculated using the comparative ΔΔCT method and the
change in miRNA or mRNA expression was calculated
as fold-change. All reactions were performed in tripli-
cate. The experiment was repeated at least three times.
Western blotting
For western blot analysis, the cells were washed twice
with ice-cold PBS and cell lysates were prepared as pre-
viously reported [39]. Then, 20 μg of each sample were
electrophoresed on a 12% SDS-polyacrylamide gel. The
proteins were then transferred onto an Immobilon-P
PVDF membrane (Millipore, Billerica, MA). After block-
ing with PBS-0.05% Tween 20 and 5% dried milk, the
membrane was probed with the following antibodies:
Slug (L40C6) from Cells Signaling Technology (Danvers,
CA, USA), ERα (sc-544), E-cadherin (sc-7870), Vimentin
(sc-7558) and p53 (sc-126) from Santa Cruz Biotechnology
(Santa Cruz, CA). After washing with PBS-Tween, the
membranes were incubated with peroxidase-conjugated
anti-rabbit antibody (1:50000) or anti-mouse (1:2000) (Dako,
Glostrup, Denmark) in 5% non-fat milk. Immunocomplexes
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(Pierce, Rockford, IL). Anti-IP3K was used to confirm equal
protein loading.
Viability analysis (calcein-AM uptake assay)
Viability assay was performed as described previously
[40]. For propidium iodide and calcein analysis the cells
were visualized under a fluorescence microscope (Nikon,
Optiphot-2, Nikon corporation, Japan) using the filter
block for fluorescein. Dead cells were stained in red,
whereas viable ones appeared in green.
Cell cycle analysis
Cell cycle analysis was performed using fluorescence-
activated cell sorting (FACS). Briefly, MDA-MB-231 cells
were collected 72 hours after transfection and stained
with 25 μg/mL of propidium iodide (Roche Molecular
Biochemicals, Indianapolis, IN) in phosphate-buffered
saline containing 0.1% bovine serum albumin, 0.05% of
Triton X-100, and 50 μg/mL of RNase A. Analysis were
carried out using FACS Scan (Becton Dickinson, NJ).
Cell proliferation assay
For growth curves analysis an equal number of cells
(approximately 3 x 104) were seeded into 24-well plates.
Twenty-four hours after transfection, the cells were
harvested and counted by trypan blue exclusion method
every day up to three days and at day 6.
Scratch wound assay
Forty-eight-hours after transfection a vertical wound was
created in the MDA-MB-231 cell layer using a 20-μL
pipette tip. Images were captured at designated times
(0 and 24 hours) to assess the rate of gap closure.
Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation (ChIP) assays were per-
formed with the ChIP assay kit (Upstate Biotechnology,
Lake Placid, NY) as previously described [38]. Briefly,
MDA-MB-231 cells were grown to 70% confluency in
DMEM supplemented with 10% FBS. Cross-linking was
performed with 1% formaldehyde at 37°C for 10 min,
the cells were washed in ice-cold PBS, and suspended in
SDS lysis buffer supplemented with 1× protease inhibi-
tor cocktail (Roche Molecular Biochemicals), for 10 min
on ice. Samples were sonicated, diluted 10-fold in dilu-
tion buffer, and precleared with 80 μl of salmon sperm
DNA-coated protein A-agarose beads; the supernatant
was used directly for immunoprecipitation with anti-
Slug, (sc-10436), anti-acetyl-H3 (sc-56616) or rabbit Ig λ
chain control antibody (sc-33134) (Santa Cruz Biotech-
nology, INC) overnight at 4°C. Immunocomplexes were
mixed with 80 μl of DNA-coated protein A-agarose
beads followed by incubation for 1 h at 4°C. Beads werecollected and sequentially washed 3 times with 1 ml
each of the following buffers: low salt wash buffer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl
pH 8.1, 150 mM NaCl), high salt wash buffer (0.1% SDS,
1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl pH-8.1,
500 mM NaCl), LiCl wash buffer (0.25 mM LiCl, 1%
IGEPAL-CA630, 1% deoxycholic acid, 1 mM EDTA,
10 mM Tris-pH 8.1), and TE buffer. The immunocom-
plexes were eluted twice by adding a 250 μl aliquot of
a freshly prepared solution of 1% SDS, 0.1 M NaHCO3
and the cross-linking reactions were reversed by incu-
bation at 65°C for 4 hrs. Further, the samples were
digested with proteinase K (10 mg/ml) at 42°C for 1
hour and DNA was purified in 50 μL of Tris–EDTA
with a PCR purification kit (Qiagen, Valencia, CA)
according to the manufacturer’s instructions. For PCR
analysis, aliquots of chromatin before immunoprecipi-
tation were saved (Input). PCR was performed to
analyze the presence of DNA precipitated by Slug-
specific antibody, and by using specific primers to
amplify fragments of the miR-221 and TRPS1 gene
promoters. Each PCR reaction was performed with 5
μl of the bound DNA fraction or 2 μl of the Input.
The PCR was performed as follows: preincubation at
95°C for 5 min, 30 cycles of 1 min denaturation at 95°C, 1 min
annealing at the primers temperature, and 1 min at 72°C, with
one final incubation at 72°C for 5 min. No-antibody negative
control was included in each experiment.
Statistical analysis
Data are presented as means ± SEM. For qRT-PCR and
cell cycle analysis assays, statistical significance was ana-
lyzed by unpaired Student’s t test. p-values ≤ 0.05 were
considered statistically significant.
Results and discussion
Correlation between Slug and miR-221 expression
The ability of miR-221 and Slug to promote EMT in
breast cancer cell lines, led us to investigate a potential
correlation between these molecules. Consistent with
previous observations, we confirmed that miR-221 and
Slug are highly expressed in breast cancer cells such as
MDA-MB-231 cell line (Figure 1A and B), and are asso-
ciated with an aggressive phenotype. However, as
demonstrated by time course experiments, miR-221 pro-
gressively decreases as cell culture proceeds (Figure 1B).
This is not surprising since a large number of miRNAs
shows distinct expression patterns that are often fluctu-
ating as a consequence of their multi-functional roles
[41,42]. Nevertheless, it is important to underline that
although evidence of a role for miRNAs in cell differen-
tiation is growing, the role of miRNAs in cell prolifera-
tion remains largely unexplored. For what concerns the












































































































































Figure 1 Effect of Slug knockdown on miR-221 expression in
breast cancer cells. MDA-MB-231 (A, B) and MDA-MB-436 (C)
breast cancer cells were transfected with 30nM si-Slug molecule or a
non-relevant siRNA (si-Scr). Slug and miR-221 expression was
determined at RNA level at three different times (24 h, 48 h, 72 h),
and revealed by quantitative RT-PCR analysis. RT-PCR results were
calculated using the ΔΔCt method and data are presented as fold
change respect to control untreated cells (Ctr 24 h for MDA-MB-231,
and Ctr 72 h for MDA-MB-436). Results represent means ± SEM of
three independent experiments. p-values ≤ 0.05 were considered
statistically significant. In panel A, Slug expression investigated at
protein level and revealed by Western Blot, is reported. IP3K was




















Figure 2 Effect of Slug knockdown on cell cycle and viability.
MDA-MB-231 cells were transfected with si-Slug molecule and
collected 72 hours after transfection. (A) Viability was determined by
double staining assay with Calcein-AM and propidium iodide.
Fluorescence photomicrographs (4X magnification) are
representative merged images showing the presence of green
fluorescence (calcein-AM)-labelled live cells and the absence of red
fluorescence (PI)-labelled dead cells. (B) Cells were subjected to
fluorescence-activated cell sorting analysis, and the relative G0/G1, S,
and G2/M compartments calculated. Percentages of cells in each
compartment are means of two independent experiments.
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ing the culture period. We then examined the effect of
Slug knockdown on miR-221 expression. The efficiency
of small interfering RNA targeting Slug (si-Slug), was
confirmed by qRT-PCR and Western blot. As shown inFigure 1A, Slug mRNA levels appreciably decreased after
24 hours, and Slug protein was almost completely abol-
ished after 72 hours. Interestingly, si-Slug, but not a
scrambled siRNA, significantly decreased miR-221 expres-
sion by 6% Figure 1B. In another ERα-negative breast can-
cer cell line, MDA-MB-436, Slug knockdown has the
same effects (Figure 1C), strengthening the hypothesis
that the presence of Slug is required for miR-221 expres-
sion. As the expression of these two molecules seems to
be particularly correlated with the aggressive phenotype,
we focused on MDA-MB-231 that are tumorigenic and
highly metastatic compared to MDA-MB-436 that are
non-tumorigenic and moderately metastatic [43,44].
The effect of Slug silencing and the resulting decrease of
miR-221 levels was evaluated on cell growth and viability
using a Calcein-AM staining and flow cytometry analysis
72 h after treatment. As shown in Figure 2A, the viability
of cells which have been transfected with siSlug was
unaffected. These data were confirmed by flow cytometry
assay. No statistically significant differences in the cell per-
centage were detected between Slug-silenced cells and
control cells in different phases of cell cycle (Figure 2B).
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The involvement of Slug in miR-221 regulation was further
investigated by chromatin immunoprecipitation (ChIP)
assay. The human genomic DNA sequences belonging to
the entire 50 regulatory region of miR-222/221 locus have
been analyzed for the presence of putative Slug binding
sites (E-box motifs, 50-CANNTG-30) [3,38], using Tran-
scription Element Search Software (TESS) for transcription
factor search and MatInspector 7.4 programs. As shown in
Figure 3, five potential candidates to mediate Slug
regulatory function in the miR-221 promoter are
present in the region. We performed ChIP analysis to
determine whether endogenous Slug transcription fac-
tor is recruited at the identified E boxes consensus
sequences. Four chromatin sub-regions were analyzed
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Figure 3 In vivo recruitment of Slug protein at the miR-221-222 loc
(5'-CAGGTG-3' or 5'-CACCTG-3') in the human miR-222/221 locus region
formaldehyde-cross linked in MDA-MB-231. Chromatin fragments were s
endogenous Slug and Acetyl Histone H3 (Ac-H3). A negative control usi
included. After cross-link reversal, the coimmunoprecipitated DNA was a
regions of miR-221 promoter (PCR amplicons are indicated by horizonta
were used as Input positive controls whereas chromatin eluted from im
control (No Ab). All experiments were repeated at least three times and
with 30 nM si-Slug molecule or a non-relevant siRNA (si-Scr). Pri-miR-221
level after 72 h of treatment, and revealed by quantitative RT-PCR analys
are presented as fold change respect to untreated cells (Ctr). Results rep
0.05 were considered statistically significant.was specifically involved in the interaction, whereas no
chromatin was immunoprecipitated by the regions 1, 2
and 4 (Figure 3A). When the ChIP assay was per-
formed against acetylated histone 3 (Anti-AcH3), a
colocalization with Slug in region 3 was detected, indi-
cating that the identified region 3 of miR-221 pro-
moter is transcriptionally active and is involved in the
binding of transcription factor Slug. As shown in
Figure 3B, following Slug silencing, the level of miR-
221/222 primary transcript significantly decreased (by
50%), further demonstrating that miR-221 is a Slug tar-
get gene and is transcriptionally regulated by Slug. At
the same time, the concomitant decrease of miR-222
expression levels, after Slug silencing, demonstrated
that Slug is involved in the regulation of the entire
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us. (A) The localization of predicted Slug consensus binding sites
is indicated with grey ovals. Protein-DNA complexes were in vivo
ubjected to immunoprecipitation with antibodies against
ng nonspecific normal rabbit antibody against Ig λ chain was also
mplified by PCR using the primers pairs spanning the reported
l bars). Aliquots of chromatin taken before immunoprecipitation
munoprecipitation lacking antibody was used as no antibody
representative images shown. MDA-MB-231 cells were transfected
(B) and miR-222 (C) expression levels were determined at RNA
is. RT-PCR results were calculated using the ΔΔCt method and data
resent means ± SEM of three independent experiments. p-values ≤
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There is evidence that many genes involved in promoting
metastasis are highly expressed both in miR-221 expres-
sing cells and in cells with high expression levels of Slug.
In addition, in the same cells, the expression of many
genes with a critical role in suppressing tumor growth and
metastasis was found to be repressed. To further evaluate





































Figure 4 Effect of Slug knockdown on the expression of specific ge
non-relevant siRNA (si-Scr). (A) E-cadherin, ERα, TRPS1 expression was de
analysis. Data are represented as fold change respect to control sample
three independent experiments. p-values ≤ 0.05 were considered statist
was determined at protein level, and revealed by Western Blot. (C) Analy
E-cadherin and TRPS1 genes. Predicted E-boxes consensus-binding site a
promoter in vivo. The localization of predicted Slug consensus binding s
reported. Protein-DNA complexes were in vivo formaldehyde-cross linke
immunoprecipitation with antibody against endogenous Slug. A negativ
chain was also included. After cross-link reversal, the coimmunoprecipita
the reported regions of TRPS1 promoter (PCR amplicons are indicated b
immunoprecipitation were used as Input positive controls whereas chro
as no antibody control (No Ab). All experiments were repeated at least tthe expression of some of these genes involved in support-
ing the breast cancer phenotype in Slug-silenced MDA-
MB-231 cells (Figure 4). Expression levels of E-cadherin
[45], ERα [36], and GATA family transcriptional repressor
TRPS1 (tricho-rhino-phalangeal syndrome type 1) [17],
were investigated by quantitative RT-PCR (Figure 4A).
ERα, p53, vimentin and E-cadherin expression was






















nes. MDA-MB-231 cells were transfected with si-Slug molecule or a
termined at mRNA level, and revealed by quantitative RT-PCR
(Ctr) for each gene analysed. Results represent means ± SEM of
ically significant. (B) ERα, p53, Vimentin, and E-cadherin expression
sis of the 2 Kb in size promoter region of Slug, ERα, p53, Vimentin,
re indicated with grey ovals. (D) Slug is recruited at TRPS1
ites (5'-CAGGTG-3' or 5'-CACCTG-3') in the human TRPS1 promoter is
d in MDA-MB-231 cells. Chromatin fragments were subjected to
e control using nonspecific normal rabbit antibody against Ig λ
ted DNA was amplified by PCR using the primers pairs spanning
y horizontal bars). Aliquots of chromatin taken before
matin eluted from immunoprecipitation lacking antibody was used
hree times and representative images shown.
Lambertini et al. BMC Cancer 2012, 12:445 Page 7 of 11
http://www.biomedcentral.com/1471-2407/12/445silencing reactivated ERα, increased E-cadherin and
TRPS1 and decreased vimentin. On the contrary, alter-
ing Slug expression levels did not affect p53 expres-
sion. Change of gene expression was not observed in










































































































Figure 5 Effect of miR-221 overexpression on the expression of speci
alone, si-Slug in combination with miR-221 mimic or a non-relevant miR (m
Scr mimic. (A) Slug, miR-221, E-cadherin, ERα, TRPS1 expression was determ
PCR results were calculated using the ΔΔCt method. Data are represented
means ± SEM of three independent experiments. p-values ≤ 0.05 were con
expression was determined at protein level, and revealed by Western Blot.
PAGE, and the proteins were visualized using Supersignal Femto Substratethat, at the molecular level, breast cancer cells with a
mesenchymal phenotype, such as MDA-MB-231, when
transfected with siRNA against Slug, decrease the
EMT program, reactivating an epithelial phenotype.







































fic genes. MDA-MB-231 cells were transfected with si-Slug molecule
iR-Scr) mimic, a non-relevant siRNA (si-Scr) in combination with miR-
ined at RNA level, and revealed by quantitative RT-PCR analysis. RT-
as fold change respect to control sample (Ctr). Results represent
sidered statistically significant. (B) Slug, ERα, Vimentin, and E-cadherin
Ten micrograms of whole cell lysates were assayed on a 12% SDS-
(Pierce). IP3K was used as loading control.
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promoter by a direct binding to E-box, has been demon-
strated by several lines of evidence [37,46-49]. This is con-
firmed by the presence of E boxes in the 50 regulatory
region of ERα, p53, vimentin, and E-cadherin genes using
TESS software (Figure 4C). The same analysis also
revealed that the promoter of TRPS1 gene contains puta-
tive Slug binding sites. ChIP analysis performed on the en-
tire sequence identified a specific involvement of region 1,
but not region 2, in the recruitment of Slug at TRPS1 pro-
moter in vivo (Figure 4D). This suggests a direct role of
Slug in the regulation of the expression of TRPS1 gene,





























































































Figure 6 Effect of Slug and miR-221 knockdown on MDA-MB-231 cell
non-relevant siRNA (si-Scr), antagomiR-221 or a non-relevant antagomiR (an
were scratch wounded with a 20-μl pipet tip (0 h), and observed over the
=100 μm. (B) Proliferation curves of MDA-MB-231 cells exposed to si-Slug,
analysis was performed si-Slug or antagomiR-221 treated cells versus untre
si-Scr or antagomiR-Scr respectively (o); p ≤ 0.05. (C) Slug and miR-221 RNA
antagomiR-Scr treatment, and results were calculated using the ΔΔCt metho
(Ctr). Results represent means ± SEM of three independent experiments. p-va
Slug, E-cadherin, ERα proteins was also analyzed by Western Blot. IP3K was usThe decrease of ERα and TRPS1 expression is a marker
of poor clinical outcome in breast cancers. Therefore,
although further investigations are required to better
understand the correlation among Slug, miR-221,
TRPS1 and ERα, nevertheless, removal of Slug and the
consequent down-regulation of miR-221 and reactivation/
increase of ERα and TRPS1, may be taken into account
for the treatment of ERα-negative breast cancer.
In order to estimate the contribution of miR-221 to
Slug-dependent gene regulation, Slug-silenced cells were
transfected with miR-221 mimic to evaluate a possible
rescue effect of miR-221 overexpression. As shown in
Figure 5, the miR-221 overexpression did not restore














migration ability. (A) Cells were transfected with 30nM si-Slug, a
tagomiR-Scr). Twenty-four hours after transfection, cells monolayer
indicated time periods, 0 and 24 hours (4x magnification). Scale bar
si-Scr, antagomiR-221 and antagomiR-Scr up to six days. Statistical
ated cells (Ctr) (*), and si-Slug or antagomiR-221 treated cells versus
levels were analysed by quantitative RT-PCR after antagomiR-221 or
d. Data are presented as fold difference respect to control untreated cells
lues ≤ 0.05 were considered statistically significant. The expression of
ed as loading control.
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cant difference of gene expression was observed in the
cells transfected with a combination of si-Scr and miR-
Scr mimic, in comparison to untreated cells. In addition,
the presence of miR-Scr mimic in si-Slug transfected
cells did not affect the effect of Slug silencing.
These results suggest that miR-221 down-modulation
has not major implications in the phenotype arising from
Slug silencing, as ectopic miR-221 expression cannot fully
rescue it. In addition, this simultaneous modulation of
Slug and miR-221 suggests that silence of Slug could sig-
nificantly protect cells from progression towards an
aggressive phenotype or metastatic stimuli that, in this
case, are represented by miR-221 overexpression.
Slug is required for cellular invasion and migration
To better characterize the correlation between Slug and
miR-221 at the functional level, the effects of their knock-
down on the invasive potential of MDA-MB-231 cells
were evaluated using the scratch-wound healing assay that
is usually employed to determine in vitro migratory ability
of the cells.
As revealed by a representative scratch assay (Figure 6A),
24 h after cell monolayers were wounded, control cells
(untreated or scrambled cells) had almost completely
filled the cleared area. On the contrary, Slug-repressed
cells, with a residual amount of miR-221 of approxi-
mately 38%, showed strongly impaired cell migration.
Therefore, gap closure in Slug repressed cells was sig-
nificantly reduced because migration from the border
of the wound was very slow.
Interestingly, complete knockdown of miR-221 expres-
sion by transfection with antagomiR-221, significantly
attenuated the gap closing in MDA-MB-231 cells, but
not as much as that observed in Slug-repressed cells.
These findings confirm the role of miR-221 in the cell
invasive potential, and its involvement in promoting the
EMT phenotype [7,8], but suggest that the largest con-
tribution to the migratory ability comes from Slug rather
than miR-221.
Data from the wound healing assay may in part be
explained with the change of cells growth ability, and in
part with the change of expression of specific genes. As
expected, Slug or miR-221 knocked down cells signifi-
cantly reduced their proliferation rate compared to con-
trol cells (untreated or scrambled cells) (Figure 6B). At
the same time, we found that miR-221 knockdown
causes a significant but not sufficient decrease of Slug
expression (Figure 6C). In fact, residual Slug mRNA
(68%) only slightly decreased the level of Slug protein, and
consequently E-cadherin expression was almost unaffected,
as revealed by Western blot analysis. This molecular evi-
dence supports the higher ability of miR-221-repressed
MDA-MB-231 cells to close the wounded area comparedto Slug-silenced cells, strengthening our hypothesis that
Slug is indeed linked to cancer cell migration and invasion
more than miR-221. In addition, as previously reported
[50], we confirm that restoration of ERα could not be
achieved by miR-221 knockdown in ERα mRNA-negative
cell lines such as MDA-MB-231 (Figure 6C), supporting
the notion that ERα is a direct target of miR-221 at the
translation level.
Furthermore, data from miR-221 knockdown suggest
that unlike Slug, probably one of its negative regulators
could be a miR-221 target. While further investigations
on a possible Slug / miR-221 circuit are needed, our data
suggest that Slug is preferable to miR-221 as potential
target to obtain inhibition or slowing down of EMT and
metastasis.
Conclusions
Taken together, the results presented here provide for the
first time evidence of a correlation between Slug transcrip-
tion factor and miR-221 in MDA-MB-231 breast cancer
cells. However, considering the complexity of EMT
phenomenon, further experiments are needed to explore
the possible Slug / miR-221 circuit, especially to under-
stand regulatory interactions with potential unknown fac-
tors acting as molecular mediators inside the loop. This
report suggests that miR-221 is, in part, dependent on Slug
in breast cancer cells, and that Slug plays a more import-
ant role than miR-221 in cell migration and invasion.
Therefore, our evidence may be useful for developing ther-
apeutical approaches for poor prognosis breast cancers.
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